Last reviewed · How we verify
NCT04013139
Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)
trial testing CPET in Ckd-Mbd in 200 participants. Completed in 1 October 2021.
1 August 2021
Quick facts
| Lead sponsor | Shahid Beheshti University of Medical Sciences |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 January 2020 |
| Primary completion | 1 August 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- CPET
Conditions studied
- Ckd-Mbd — all drugs for Ckd-Mbd →
Sponsor
Shahid Beheshti University of Medical Sciences
Who can join
18 and older, any sex, with Ckd-Mbd. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Reductions in exercise capacity associated with exercise intolerance augment cardiovascular disease risk and predict mortality in chronic kidney disease. This study utilized cardiopulmonary exercise testing to (a) investigate mechanisms of exercise intolerance; (b) unmask subclinical ca and p and vitamin D abnormalities that may precede cardiovascular disease in chronic kidney disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04013139
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CPET
Trials testing the same drug.
- NCT07347535 — Non-invasive MSOT Examination of Muscle Oxygenation in Athletes and PAD Patients · not yet recruiting
- NCT05229250 — NIRS and Exercise Intensity in Patients With FLIA · terminated
- NCT05483179 — Association Between New Effort-independent Cardiopulmonary Exercise Test Variables and Postoperative Complications After · completed
- NCT01033266 — Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome · completed
Other recruiting trials for Ckd-Mbd
Currently open trials in the same condition.
- NCT06416761 — Genetics in the Progression of Nephropathies · recruiting
Other Shahid Beheshti University of Medical Sciences trials
Trials by the same sponsor.
- NCT07005687 — Using MSCs for Chronic Active Antibody Mediated Rejection · NA · not yet recruiting
- NCT07435558 — Homogeneous vs. Heterogeneous Learning Style Grouping in Problem-Based Learning Among Nurses · NA · not yet recruiting
- NCT07408492 — Impact of AI-Based Research Training on Nursing Students · NA · not yet recruiting
- NCT07176663 — Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure · NA · not yet recruiting
- NCT07291622 — Synchrony-Optimized Non-Invasive Ventilation Education Program and ICU Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04013139 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shahid Beheshti University of Medical Sciences
- Last refreshed: 28 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04013139.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing